Molecular biology tools company Zymo Research said on Tuesday that it plans to introduce its ready-to-go processing solution to streamline viral DNA/RNA extraction from nasopharyngeal swabs, oropharyngeal swabs, saliva, sputum, plasma and serum, in partnership with Tecan.
The DreamPrep NAP workstation, which features Zymo Research's Quick-DNA/RNA Viral MagBead Kit, provides pre-loaded scripts and optimized for viral RNA extraction, which are currently being validated for COVID-19 assays by high complexity testing labs.
Zymo's DreamPrep NAP workstation workflows require time-consuming scripting, configuration and optimization for the nucleic acid extraction to function properly, which can dramatically decrease lab scalability in this critical time.
In addition, the preprogrammed, preconfigured, load-and-go system is optimized for high-throughput viral RNA extraction. The workstation features a user-friendly interface and guided setup to streamline implementation, concluded the partnership.
ACM Biolabs reports ACM-CpG Phase 1 study findings in tumour treatment
Galera Therapeutics sells dismutase mimetics portfolio to Biossil in USD108.5m agreement
Arcturus reports interim Phase 2 data for ARCT-032 in cystic fibrosis
Sanofi's efdoralprin alfa shows superior results in phase 2 study for AATD
Genflow Biosciences publishes second European patent application for SIRT6 Variant in NASH
Trellus Health signs contract with leading global CRO and expands clinical trial offerings
GSK reports positive Phase III data for low-carbon version of Ventolin inhaler
Terns Pharmaceuticals reports topline 12-week data from Phase 2 trial of TERN-601 in obesity
The Los Angeles Trust for Children's Health Appoints Dr Sarah Rodman as New Executive Director
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
Genentech's Gazyva (obinutuzumab) receives US FDA approval to treat adults with lupus nephritis
ACG to invest USD200m in US hard-shell capsule manufacturing